Towards a national pharmaceutical strategy in Lebanon: Ensuring access to quality and safe medications for all

被引:3
|
作者
Sacre, Hala [1 ,2 ]
Hamra, Rasha [3 ]
Hassoun, Carole [4 ]
Hanna, Marie -Louise A. [5 ]
Ghossoub, Marie [1 ]
Jaber, Joumana [5 ]
Hajj, Aline [2 ,6 ,7 ,8 ]
Akel, Marwan [2 ,9 ,10 ]
Zeenny, Rony M. [2 ,11 ]
Mina, Wadih [4 ]
Rached, Roula [4 ]
Chourbaji, Wael [4 ]
El Hajj, Samar [4 ]
Ziade, Bassame [4 ]
Gebrael, Rawad [4 ]
Sleiman, Ali [4 ]
Traboulsi, Lina [12 ]
Karam, Carol Abi [5 ]
El Rifai, Omar [3 ]
Salamen, Pascal [1 ,2 ,13 ,14 ,15 ]
机构
[1] Order Pharmacists Lebanon, Sci Comm, Pierre Gemayel St, Beirut, Lebanon
[2] Inst Natl St Publ Epidemiol Clin & Toxicol Liban I, Beirut, Lebanon
[3] World Hlth Org, Lebanon Country Off, Beirut, Lebanon
[4] Lebanese Pharm Grp LPG, Beirut, Lebanon
[5] Syndicate Pharmaceut Ind Lebanon SPIL, Beirut, Lebanon
[6] St Joseph Univ Beirut, Fac Pharm, Lab Pharmacol Pharm Clin & Controle Qual Medicamen, Beirut, Lebanon
[7] Univ Laval, Fac Pharm, Quebec City, PQ, Canada
[8] CHU Quebec Univ Laval Res Ctr, Oncol Div, Quebec City, PQ, Canada
[9] Lebanese Int Univ, Sch Pharm, Beirut, Lebanon
[10] Int Pharmaceut Federat FIP, The Hague, Netherlands
[11] Amer Univ Beirut, Dept Pharm, Med Ctr, Beirut, Lebanon
[12] Order Malta, Beirut, Lebanon
[13] Lebanese Univ, Fac Pharm, Hadat, Lebanon
[14] Lebanese Amer Univ, Sch Med, Byblos, Lebanon
[15] Univ Nicosia Med Sch, Dept Primary Care & Populat Hlth, CY-2417 Nicosia, Cyprus
来源
PHARMACY EDUCATION | 2023年 / 23卷 / 01期
关键词
Access to medication; LMIC; Pharmaceutical strategy; Quality medication; Stakeholder; PRESCRIPTION; COMMUNITY;
D O I
10.46542/pe.2023.231.165179
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Introduction: Lebanon is facing challenges affecting the whole health sector, including access to medications. Lebanon has only proposed very few short-term national pharmaceutical strategic solutions. Previous reform attempts targeting the pharmaceutical sector, could not protect it from the crises and their detrimental consequences on patient and population health. Purpose: This document unveils the critical elements that should be addressed in the planned National Pharmaceutical Sector Strategy (NPS) being developed by the Order of Pharmacists of Lebanon (OPL) in consultation with the concerned stakeholders. Method: Strategic goals were proposed for adoption and implementation by the competent authorities based on consultations, situational assessments, and gap analyses. The objectives and an implementation plan were developed based on the available resources and policy dialogue, respectively. Conclusion: The National Pharmaceutical Strategy would help the Lebanese authorities/policy-makers, aided by competent healthcare professionals, develop and implement a time-bound roadmap to attain a nation with access to quality and safe medications for the whole population. Implementing this strategy would require the commitment of decision-makers, the accountability of involved parties, innovation in finding solutions, close collaboration between stakeholders, and lengthy efforts to attain the stated vision.
引用
收藏
页码:165 / 179
页数:15
相关论文
共 16 条
  • [1] Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals
    Akel, Marwan
    Hajj, Aline
    Sacre, Hala
    Zeenny, Rony M.
    Haddad, Chadia
    Salameh, Pascale
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2022, 15 (01)
  • [2] Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals
    Marwan Akel
    Aline Hajj
    Hala Sacre
    Rony M. Zeenny
    Chadia Haddad
    Pascale Salameh
    Journal of Pharmaceutical Policy and Practice, 15
  • [3] National policies in ensuring access to quality and safety of drugs: A challenge or a prerequisite
    Dehshal, M. Hadipour
    Namini, M. Tabrizi
    THALASSEMIA REPORTS, 2018, 8 (01) : 53 - 56
  • [4] Challenge of ensuring access to high-quality emergency surgical care for all
    Scott, John W.
    Dimick, Justin B.
    BMJ QUALITY & SAFETY, 2020, 29 (08) : 613 - 614
  • [5] Ensuring Quality Science From "R" to "D": An Optimal Adoption Strategy for In-Licensing of Pharmaceutical Innovation
    Zhao, Guozhen
    Chen, Wen
    IEEE TRANSACTIONS ON ENGINEERING MANAGEMENT, 2011, 58 (04) : 643 - 661
  • [6] Towards a Dutch National Tissuebank Portal: One portal to access all pathology archives for research
    Overbeek, L.
    Steegers, C.
    Hoffman, A.
    Hijmering, N.
    van Kemenade, F.
    Meijer, G.
    VIRCHOWS ARCHIV, 2015, 467 : S237 - S237
  • [7] Disparities by Sex Tracked in the 2015 National Healthcare Quality and Disparities Report: Trends across National Quality Strategy Priorities, Health Conditions, and Access Measures
    Moore, Jennifer E.
    Mompe, Atlang
    Moy, Ernest
    WOMENS HEALTH ISSUES, 2018, 28 (01) : 97 - 103
  • [8] The influence of PHARMAC's National Hospital Pharmaceutical Strategy on Quality Use of Medicines activities in New Zealand hospitals
    Tordoff, June
    Norris, Pauline
    Kennedy, Julia
    Reith, David
    NEW ZEALAND MEDICAL JOURNAL, 2006, 119 (1239) : 21 - 32
  • [9] Invited Perspective: Beyond National Water Quality Surveys: Improving Water Quality Surveillance to Achieve Safe Drinking Water for All (Sustainable Development Goal 6.1)
    Charles, Katrina J.
    Greggio, Ellen
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2021, 129 (09)
  • [10] Creating a safe, high-quality healthcare system for all: meeting the needs of limited English proficient populations; Comment on "Patient safety and healthcare quality: the case for language access"
    Betancourt, Joseph R.
    Tan-McGrory, Aswita
    INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT, 2014, 2 (02): : 91 - 94